Energy & Commerce's Subcommittee on Health to Hold Pharmacy Compounding Hearing on Tuesday, January 30, 2018
IACP Invited as Invitation-only Witness
The U.S. House of Representatives' Committee on Energy & Commerce's Subcommittee on Health will hold a hearing on Tuesday, January 30, 2018, at 11:00 a.m. Eastern Time in 2123 Rayburn House Office Building. The hearing is entitled,"Examining Implementation of the Compounding Quality Act."
The International Academy of Compounding Pharmacists (IACP) has been invited to serve as a witness by the Subcommittee on Health chaired by U.S. Congressman Michael C. Burgess, MD (TX).
IACP Vice President Shawn Hodges, PharmD, will serve as a witness representing 503A compounding pharmacies. Please click here to view Shawn's bio. On behalf of the IACP Board of Directors, we thank Shawn for his willingness and dedication to serve our profession at this hearing.
The full witness list willl be announced by the E&C Subcommittee on Health on this webpage as soon as made available; all witnesses are invitation only. IACP will provide our members with this list as soon as it's available.
PLEASE NOTE: The hearing webcast will be made publicly available at
IACP is working on your patients' behalf to protect access to compounded medications! This hearing is a critical opportunity to present the value and necessity compounded medications bring to patients and the providers who serve them.
Please email IACP with questions or comments at firstname.lastname@example.org. We will make you aware of any developments on this hearing.